BRIEF published on 04/03/2025 at 13:24, 1 year 6 months ago Innate Pharma participates in the Stifel 2025 Virtual Targeted Oncology Forum Euronext Paris Oncology Immunotherapy Innate Pharma Virtual Forum
PRESS RELEASE published on 04/03/2025 at 13:19, 1 year 6 months ago INFORMATIONS PRIVILÉGIÉES / AUTRES COMMUNIQUÉS Innate Pharma annonce sa participation au Stifel 2025 Virtual Targeted Oncology Forum. Présentation prévue le 9 avril 2025. Informations sur les traitements innovants contre le cancer Immunothérapie Cancer Oncologie Innate Pharma Stifel 2025
BRIEF published on 04/03/2025 at 13:18, 1 year 6 months ago Innate Pharma to Engage in Stifel 2025 Virtual Oncology Forum Biotechnology Immunotherapy Virtual Event Innate Pharma Oncology Forum 2025
BRIEF published on 04/03/2025 at 13:18, 1 year 6 months ago Innate Pharma participera au forum virtuel d'oncologie Stifel 2025 Biotechnologie Immunothérapie Événement Virtuel Innate Pharma Forum D'oncologie 2025
PRESS RELEASE published on 04/03/2025 at 13:13, 1 year 6 months ago INSIDE INFORMATION / OTHER NEWS RELEASES Innate Pharma to participate in 2025 Stifel Virtual Targeted Oncology Forum. Executive team presenting and hosting 1x1 meetings. Focus on innovative cancer immunotherapies Cancer Innate Pharma Immunothérapies Stifel Targeted Oncology Forum
PRESS RELEASE published on 03/28/2025 at 14:37, 1 year 7 months ago Annual financial and audit reports / Annual financial report
PRESS RELEASE published on 03/28/2025 at 14:32, 1 year 7 months ago Rapports financiers et d'audit annuels / Rapport financier annuel
BRIEF published on 03/20/2025 at 07:05, 1 year 7 months ago Innate Pharma annonce une conférence sur les résultats financiers 2024 Résultats Financiers Conférence Téléphonique Cotation Boursière Innate Pharma Immunothérapie Cancer
BRIEF published on 03/20/2025 at 07:05, 1 year 7 months ago Innate Pharma Announces 2024 Financial Results Conference Financial Results Conference Call Stock Market Listing Cancer Immunotherapy Innate Pharma
PRESS RELEASE published on 03/20/2025 at 07:00, 1 year 7 months ago Informations privilégiées / Autres communiqués Innate Pharma organise une conférence téléphonique et un webcast pour présenter ses résultats financiers 2024. Détails de l'événement et informations pratiques disponibles sur www.innate-pharma.com Résultats Financiers Webcast Conférence Téléphonique Innate Pharma Biotechnologies
Published on 10/28/2026 at 12:30, 3 hours 44 minutes ago Digi Power X to Announce 2026 Q3 Financial Results and Provide Operations Update on November 13th
Published on 10/28/2026 at 12:30, 3 hours 44 minutes ago AI/ML Innovations Announces Advance Notice Provisions
Published on 10/28/2026 at 12:30, 3 hours 44 minutes ago Sterling Expands Mineralized Footprint to 2km With Near Surface Intercept in 850m Eastern Step Out
Published on 10/28/2026 at 12:30, 3 hours 44 minutes ago Ameriwest Reports Additional High-Grade Copper Results from Historical Drill Core at Bornite Including 71.0 Feet (21.6 Meters) at 8.08% CuEq
Published on 10/28/2026 at 12:15, 3 hours 59 minutes ago BULGOLD Expands Strategic Exploration Position Around the Lutila Gold Project with Two New Exploration Licences
Published on 10/28/2026 at 15:18, 55 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle PLC
Published on 10/28/2026 at 15:18, 55 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC
Published on 10/28/2026 at 08:00, 8 hours 13 minutes ago Edenred successfully raises €800 million in a dual-tranche bond offering
Published on 10/28/2026 at 08:00, 8 hours 13 minutes ago Edenred lève avec succès 800 millions d’euros dans le cadre d’une émission obligataire à deux tranches
Published on 10/27/2026 at 18:00, 22 hours 14 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 22, 2026
Published on 10/27/2026 at 18:00, 22 hours 14 minutes ago Nombre total de droits de vote et actions composant le capital social au 22 octobre 2026
